Education
About Us
Working with TipRanks
Follow Us
Roivant Sciences (ROIV)
NASDAQ:ROIV
Earnings Data
Report Date
Feb 16, 2026Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.3Last Year’s EPS
0.23Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive overall sentiment with significant progress in the pipeline, particularly with the upcoming brepocitinib data, a strong financial position, and strategic share repurchase programs. However, challenges remain with ongoing LNP litigation and complexities in clinical trial management.Company Guidance
Upcoming Brepocitinib Data
Brepocitinib, a drug with a well-established safety profile in over 1,500 patients, is approaching a pivotal trial data release that could redefine the standard of care for dermatomyositis (DM).
Share Repurchase Program
Completed a $1.5 billion share repurchase program, reducing share count by over 15%. An additional $500 million repurchase program has been authorized.
Strong Financial Position
Roivant holds $4.5 billion in cash with no debt, providing a strong financial position for future growth and development.
Pipeline Progress
Significant progress across the pipeline, including multiple registrational trials for IMVT-1402 and rapid advancement of brepocitinib in various indications.
ROIV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ROIV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 10, 2025 | $20.62 | $21.17 | +2.67% |
Aug 11, 2025 | $11.49 | $11.17 | -2.79% |
May 29, 2025 | $10.62 | $11.30 | +6.40% |
Feb 10, 2025 | $10.89 | $10.79 | -0.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Roivant Sciences (ROIV) report earnings?
Roivant Sciences (ROIV) is schdueled to report earning on Feb 16, 2026, Before Open (Confirmed).
What is Roivant Sciences (ROIV) earnings time?
Roivant Sciences (ROIV) earnings time is at Feb 16, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ROIV EPS forecast?
ROIV EPS forecast for the fiscal quarter 2025 (Q3) is -0.3.